MedPath

IV Lidocaine Analgesia in Pediatric Scoliosis Surgery

Phase 3
Completed
Conditions
Scoliosis; Adolescence
Anesthesia Recovery Period
Interventions
Drug: Saline Solution
Registration Number
NCT04069169
Lead Sponsor
University of British Columbia
Brief Summary

Surgical correction of scoliosis in children is a long procedure, with an equivalently long recovery time, that is commonly performed at BC Children's Hospital. Treating pain immediately after the procedure is a priority for children during recovery. Morphine is one medication that can be used to manage post-operative pain, but unfortunately, its use is accompanied by a number of side effects which can affect recovery. These include nausea, vomiting, pruritus, sedation, dysphoria, respiratory depression, constipation, ileus, and urinary retention.

In order to control pain and reduce morphine consumption, intravenous lidocaine is being investigated. This therapy has been beneficial in adult populations undergoing abdominal surgery and has been associated with decreased post-operative pain, decrease use of opioids including morphine, and ileus. These all contribute to shorter lengths of stay in the hospital and better recovery in the adult population.

Intravenous lidocaine is used by some anesthesiologists at BC Children's Hospital to manage post-operative pain in children receiving surgical correction for scoliosis, but this is not a standard of practice. We now propose to conduct a double-blind randomized controlled trial to determine if intravenous lidocaine, infused from start of anesthesia up to 48 hours post-operatively, will reduce morphine use and improve post-operative pain in the pediatric population.

Detailed Description

Objectives:

The primary objective of this study is to determine if perioperative IV lidocaine therapy (P-IVLT) reduces 48-hour post-operative morphine utilization compared with a control, in adolescents undergoing PSIF. Secondary objectives of this study are to determine the effect of P-IVLT on self-reported pain scores, time to documented first stand, time to first walk of greater than 15 steps, and length of hospital stay (LOS).

Research Methods:

This will be a placebo-controlled, double-blind randomized control trial (RCT) comparing 48-hour postoperative morphine utilization among adolescents undergoing PSIF who have been randomly assigned to one of two groups:

Intervention group (A) will receive P-IVLT in addition to the standard multimodal analgesia. P-IVLT will consist of 1 mg/kg bolus at start of anesthesia (T0), followed by 2 mg·kg-1·hr-1 infusion for 8 hours (T1), then continued at 1 mg·kg-1·hr-1 infusion thereafter and postoperatively until T0 + 48 hours (T2).

Control group (B) will receive a placebo (0.9% sodium chloride also known as normal saline), made to mimic the intervention protocol above, in addition to the standard multimodal analgesia.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • ASA I-III
  • Diagnosed with Idiopathic scoliosis
  • Undergoing single-stage posterior spinal instrumentation and fusion
Exclusion Criteria
  • Thorascopic tethering procedure
  • Two-stage procedure
  • Abnormal developmental profile
  • Congenital/neuromuscular scoliosis
  • Requiring PICU admission
  • Known allergy to lidocaine
  • Known cardiac, renal or liver disease or dysfunction
  • Pre-existing pain complaints, i.e. on regular analgesic medications
  • Current psychiatric diagnosis, e.g. anxiety, depression, eating disorder, defined according to DSM criteria.
  • Requiring non-standard post-op pain management
  • Any history of seizures
  • Unplanned staged procedure
  • Weight < 5th centile or > 85th centile for age
  • Porphyria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intravenous lidocaineLidocaine1% preservative free lidocaine 10 mg/ml in 0.9% NaCl
Intravenous saline controlSaline Solution0.9% sodium chloride, also known as normal saline
Primary Outcome Measures
NameTimeMethod
Total morphine utilization48 hours post-operatively

Documented from acute pain service charts (mg/kg)

Secondary Outcome Measures
NameTimeMethod
Mobililzationthrough hospital stay, an average of 5 days

Time from anesthesia induction to first walk of greater than 15 steps (hours)

Urinary incontinencethrough hospital stay, an average of 5 days

Time from anesthesia induction to urinary catheter removal (hours)

Postoperative painfrom emergence in the anesthetic care unit through 48 hours post-operatively

Pain scores measured every 4 hours by nursing staff

Postoperative pain (II)through study completion, 48 hours post-operatively

Time from anesthesia induction to termination of morphine (hours)

Recoverythrough hospital stay, an average of 5 days

Time from anesthesia induction to discharge from hospital (days)

Total morphine utilization12, 24, 36 hours post-operatively

Documented from acute pain service charts (mg/kg)

Trial Locations

Locations (1)

BC Children's Hospital - Department of Anesthesia

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath